![Biotech Stocks Facing FDA Decision In June 2022]( "collage-0526.jpg")
As another month comes to a close, it’s time to take a look back at some of the healthcare sector news that made headlines in May and look ahead to what’s in store on the regulatory front in June.
![Biotech Stocks Facing FDA Decision In March 2022]( "fda-feb25.jpg")
As another month comes to an end, it’s time to take a look back at some of the regulatory news that made headlines in February and look ahead to what the month of March has in store.
![Biotech Stocks Facing FDA Decision In January 2022]( "fda-dec27.jpg")
As another month comes to an end, we take a look back at some of the regulatory news that dominated the headlines and look ahead to what’s in store for January.
![Biotech Stocks Facing FDA Decision In December 2021]( "fda-nov29.jpg")
Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa earlier this month, Omicron cases have now been reported in at least 15 countries.